Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

CJC-1295 (no DAC) Dosage & Reconstitution

Mod GRF 1-29, Sermorelin analogue. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

3.333 mg/mL · 3333 mcg/mL

Your Answer — CJC-1295 (no DAC)

10 mg in 3 mL
3Draw To This Line
0.03That's This Many mL
100Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 3
10 mg ÷ 3 mL = 3.333 mg/mL  →  100 mcg ÷ 3.333 mg/mL = 0.03 mL  →  × 100 = 3 units
Looks good. Draw to 3 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 100 doses.
When to dose
Time of dayBefore bed, or first thing in the morning — not during the day.
FoodFasted. Nothing to eat for about 2 hours before, and wait 20–30 minutes after.

Food, and carbohydrate in particular, raises insulin and blunts the growth-hormone pulse these compounds are meant to trigger. The two windows where you are naturally fasted and GH release is highest are early sleep and first thing on waking, which is why those are the only two sensible times.

2Week-By-Week Plan — CJC-1295 (no DAC)

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Weeks 1–2 100 mcg daily 0.03 mL 3 u 14 1.4 mg
Week 3 onward
per 4 weeks from here on
200 mcg daily 0.06 mL 6 u 28 5.6 mg
Time until the top dose
2 weeks
Peptide used getting there
1.4 mg
Vials you'll need
1 × 10 mg
Once you're at the top dose
5.6 mg / 4 wk · 0.56 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — CJC-1295 (no DAC)

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Low reported 100 mcg 1× daily 0.03 mL 3 u 100 doses
Standard 100 mcg 2–3× daily 0.03 mL 3 u 100 doses
Upper reported 200 mcg 1–3× daily 0.06 mL 6 u 50 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About CJC-1295 (no DAC)

GH Secretagogue
Also known as
Mod GRF 1-29, Sermorelin analogue
Class
GH Secretagogue
Route
Subcutaneous
Half-life
~30 min
Evidence tier
Preclinical

A tetra-substituted GHRH(1-29) analogue without the drug affinity complex, giving a short pulse rather than sustained elevation. Frequently paired with a GHRP on the rationale of hitting two complementary receptors.

Buy CJC-1295 (no DAC)

Common Questions — CJC-1295 (no DAC)

How much bacteriostatic water do I add to a 10 mg vial of CJC-1295 (no DAC)?

Adding 3 mL of bacteriostatic water to a 10 mg vial gives 3.33 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of CJC-1295 (no DAC) is used in research?

Published and reported figures for CJC-1295 (no DAC) run from 100 mcg to 200 mcg, typically 1× daily. This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 100 mcg dose of CJC-1295 (no DAC)?

At 3.33 mg/mL, a 100 mcg dose is 3 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 100 doses.

How strong is the evidence behind these CJC-1295 (no DAC) doses?

CJC-1295 (no DAC) is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
GHRH(1-29) analogues and growth hormone pulsatility Teichman SL, et al. Journal of Clinical Endocrinology & Metabolism, 2006
Human PK/PD for the CJC-1295 series, including with and without DAC.
Find on PubMed ↗
Growth hormone-releasing hormone and its analogues Khorram O, Laughlin GA, Yen SSC. JCEM, 1997
Foundational human GHRH physiology.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Need this on one page to print, screenshot or send?

Make a dose card →

Other gh secretagogue peptides

Compounds in the same class, or browse the full catalogue.

CJC-1295 DAC

GHRH analogue conjugated to bind serum albumin, extending half-life from minutes to days. This produces sustained GH/IGF-1 elevati…

GHRP-2

A growth hormone-releasing peptide with an approved diagnostic use in Japan for GH deficiency testing. Less receptor-selective tha…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.